1. Logue CM, Moos RH. Perimenstrual symptoms: prevalence and risk factors. Psychosom Med 1986;48:388-414.
2. Moline ML, Zendell SM. Evaluating and managing premenstrual syndrome. Medscape Womens Health 2000;5:1-16.
3. Daugherty JE. Treatment strategies for premenstrual syndrome. Am Fam Physician 1998;58:183-192. 197-198.
4. Freeman EW, Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. Am J Psychiatry 1999;156:1403-1408.
5. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Harrison W, et al. Sertraline Premenstrual Dysphoric Collaborative Study Group. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment A randomized controlled trial. JAMA 1997;278:983-988.
6. Goodale IL, Domar AD, Benson H. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol 1990;75:649-655.
7. Johnson WG, Carr-Nangle RE, Bergeron KC. Macronutrient intake, eating habits, and exercise as moderators of menstrual distress in healthy women. Psychosom Med 1995;57:324-330.
8. Plouffe L Jr, Stewart K, Craft KS, Maddox MS, Rausch JL. Diagnostic and treatment results from a southeastern academic center-based premenstrual syndrome clinic: the first year. Am J Obstet Gynecol 1993;169:295-307.
9. American College of Obstetricians and Gynecologists, Committee on Gynecologic Practice. Premenstrual syndrome. ACOG committee opinion no. 155. Int J Gynecol Obstet 1995;50:80-84.
10. Sayegh R, Schiff I, Wurtman J, Spiers P, McDermott J, Wurtman R. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995;86:520-528.
11. Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999;318:1375-1381.
12. London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987;32:400-404.
13. Thys-Jacobs S, Starkey P, Bernstein D, Tain J. Premenstrual Syndrome Study Group. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444-452.
14. Walker AF, De Souza MC, Vickers MF, Abeyasekera S, Collins ML, Trinca LA. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998;7:1157-1165.
15. Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 1990;153:189-192.
16. Budeiri D, Li Wan, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996;17:60-68.
17. Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ. Full-or half cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J Clin Psychopharmacol 1999;19:3-8.
18. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-1136.
19. ACOG practice Bulletin. Clinical management guidelines for obstetrician-gynecologist Number 15 April 2000. Premenstrual syndrome. Obstet Gynecol 2000;95:1-9.
20. Steiner M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 1997;33:771-774.
21. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Eriksson E, et al. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998;18:390-398.
22. Smith S, Rinehart JS, Ruddock VE, Schiff I. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol 1987;70:37-43.
23. Sundblad C, Hedberg MA, Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 1993;9:133-145.
24. Wang M, Hammarback S, Lindhe BA, Backstrom T. Treatment of premenstrual syndrome by spironolactone: a double-blind placebo-controlled study. Acta Obstet Gynecol Scand 1995;74:803-808.
25. Gunston KD. Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid. S Afr Med J 1986;70:159-160.
26. O'Brien PM, Abukhalil IE. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999;180:18-23.
27. Hahn PM, Van Vugt DA, Reid RL. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995;20:193-209.
28. Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994;84:779-786.
29. Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T. Treatment of remenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 1999;78:891-899.
30. Di Carlo C, Palomba S, Tommaselli GA, Guida M, Di Spiezio Sardo A, Naooi C. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 2001;75:380-384.
31. Leather AT, Studd JW, Watson NR, Holland EF. The treatment of severe premenstrual syndrome with goserelin with and without add-back estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999;13:48-55.
32. Taskin O, Gokdeniz R, Yalcinoglu A, Buhur A, Burak F, Ozekici V, et al. Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod 1998;13:2402-2405.
33. Andersch B, Hahn L. Premenstrual complaints II. Influence of oral contraceptives. Acta Obstet Gynecol Scand 1981;60:579-583.
34. Graham CA, Sherwin BB. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms. Psychoneuroendocrinology 1993;18:273-281.
35. Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001;10:561-569.
36. Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician 2003;67:1743-1752.
37. Braiden V, Metcalf G. Premenstrual tension among hysterectomized women. J Psychosom Obstet Gynaecol 1995;16:145-151.